Back to discover
Drug

Dihematoporphyrin Ether

Research stage
Emerging research

Also known as DHP ether, PORFIMER, Photofrin, bis-1-(8-(1-hydroxyethyl)deuteroporphyrin-3-yl)ethyl ether.

RxNorm23066UNII625J2HS54G
1
Research papers
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Photodynamic therapy.

Research1998-06-01Journal of the National Cancer Institute

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Dihematoporphyrin Ether
Aliases & brands
DHP etherPORFIMERPhotofrinbis-1-(8-(1-hydroxyethyl)deuteroporphyrin-3-yl)ethyl ether
RxNorm CUI
23066
UNII
625J2HS54G

Research activity

1 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Most influential

Photodynamic therapy.

Journal of the National Cancer Institute · 1998 · 3,227 cites
Recent papers

Photodynamic therapy.

Journal of the National Cancer Institute · 1998 · 3,227 cites
Major research themes1
Photochemotherapy1
Journals, researchers & institutions
Top journals
  • Journal of the National Cancer Institute1
Leading researchers
  • Dougherty TJ1
  • Gomer CJ1
  • Henderson BW1
  • Jori G1
  • Kessel D1
  • Korbelik M1
  • Moan J1
  • Peng Q1
Leading institutions
free-text, unnormalised
  • Photodynamic Therapy Center1
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • Europe PMC — research literature